Auzinger G, Playford GE, Graham CN, Knox HN, Weinstein D, Kantecki M, Schlamm H, Charbonneau C. Cost-effectiveness analysis of anidulafungin for the treatment of candidaemia and other forms of invasive candidiasis. BMC Infect Dis. 2015 Oct 26;15:463. doi: 10.1186/s12879-015-1143-1
Auzinger G, Playford G, Graham CN, Narula H, Charbonneau C, Weinstein D. Cost-effectiveness analysis of anidulafungin in the treatment of candidaemia. Poster presented at the International Symposium of Intensive Care and Emergency Medicine; March 2012.
Graham CN, Earnshaw SR, Raymond V. Cost-effectiveness of anidulafungin therapy in confirmed candidemia and other forms of invasive candidiasis in Canada. Poster presented at the 2008 ISPOR 13th Annual International Meeting; May 2008. [abstract] Value Health. 2008 May; 11(3):A98.
Earnshaw SR, Graham CN, Gasper S. Cost-effectiveness of anidulafungin therapy in confirmed candidemia and other forms of invasive candidiasis. Poster presented at the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); September 2007.
Shearer A, Gazzard B, Graham CN, Davis EA, Mauskopf J, Kitahata M, Saag MS, Earnshaw SR. Simulation modeling of adherence and resistance on long-term outcomes in HIV. Poster presented at the Infectious Disease Society of America 44th Annual Meeting; October 15, 2006.